The stability of this compound in solution, specifically in DMSO, has not been evaluated. However, external sources note that Budesonide is stable in DMSO for up to 1 year at -20°C or up to 2 years at -80°C. Store in working aliquots, avoid repeated freeze/thaw cycles.
B7777
Budesonide
≥99%, anti-inflammatory, powder
Sinonimo/i:
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| A voi/SKU | Disponibilità | Prezzo |
|---|---|---|
250 mg | Per informazioni sulla disponibilità, contatta il Servizio Clienti. | 224,00 € |
Informazioni su questo articolo
Formula empirica (notazione di Hill):
C25H34O6
Numero CAS:
Peso molecolare:
430.53
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
257-139-7
MDL number:
Assay:
≥99%
Form:
powder
224,00 €
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiNome del prodotto
Budesonide, ≥99%
Quality Segment
assay
≥99%
form
powder
originator
AstraZeneca
SMILES string
[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]4(C)[C@@]2([H])C[C@H]5OC(CCC)O[C@@]45C(=O)CO
InChI
1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
InChI key
VOVIALXJUBGFJZ-KWVAZRHASA-N
Gene Information
human ... IFNG(3458), IL5(3567), NR3C1(2908)
rat ... Nr3c1(24413)
Biochem/physiol Actions
Second generation glucocorticoid with low systemic absorption; anti-inflammatory agent; inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein.
Budesonide is a second generation glucocorticoid with low systemic absorption. It is used as an anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease. It inhibits the expression of chemokine mRNA and production of eotaxin and RANTES protein in primary human bronchial epithelial cells. Budesonide is currently in clinical trials for the prevention of lung cancer. It shows inhibitory effects on benzo[a]pyrene-induced carcinogenesis of the lung in mice.
Features and Benefits
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
1 of 1
Questo articolo | |||
|---|---|---|---|
| form powder | form - | form - | form - |
| assay ≥99% | assay ≥97% | assay - | assay - |
| Quality Level 200 | Quality Level 200 | Quality Level - | Quality Level - |
| originator AstraZeneca | originator Roche | originator - | originator - |
| Gene Information human ... IFNG(3458), IL5(3567), NR3C1(2908) | Gene Information - | Gene Information human ... NR3C1(2908) | Gene Information - |
Still not finding the right product?
Explore all of our products under Budesonide
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 2 - Skin Sens. 1 - STOT RE 1 Inhalation
target_organs
Adrenal gland
Classe di stoccaggio
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
-
I resuspended 250mg in 581µl of DMSO (soluble). How should I store this and for how long can I keep it. Thank you in advance :)
1 risposta-
Utile?
-